Onconova Therapeutics, Inc. (ONTX) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 215 transactions totaling $55.0M, demonstrating a bullish sentiment with $49.0M in net insider flow. The most recent transaction on Mar 14, 2024 involved a transaction of 8,727 shares valued at $7.9K.
No significant insider buying has been recorded for ONTX in the recent period.
No significant insider selling has been recorded for ONTX in the recent period.
Based on recent SEC filings, insider sentiment for ONTX is bullish with an Insider Alignment Score of 94/100 and a net flow of $49.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Onconova Therapeutics, Inc. (ONTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading ONTX stock, having executed 215 transactions in the past 90 days. The most active insider is Michael B. Hoffman (Executive), who has made 30 transactions totaling $19.6M.
Get notified when executives and directors at ONTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | M. Fruchtman Steven | Executive | Payment | 8,727 | $0.90 | $7.9K | |
| Mar 14, 2024 | Patrick Guerin Mark | Executive | Payment | 2,591 | $0.90 | $2.3K | |
| Mar 13, 2024 | M. Fruchtman Steven | Executive | Option Exercise | 23,111 | $N/A | $0 | |
| Mar 13, 2024 | Patrick Guerin Mark | Executive | Option Exercise | 8,666 | $N/A | $0 | |
| Feb 7, 2024 | M. Fruchtman Steven | Executive | Option Exercise | 21,320 | $N/A | $0 | |
| Feb 7, 2024 | M. Fruchtman Steven | Executive | Payment | 9,212 | $0.67 | $6.2K | |
| Feb 7, 2024 | Patrick Guerin Mark | Executive | Option Exercise | 6,900 | $N/A | $0 | |
| Feb 7, 2024 | Patrick Guerin Mark | Executive | Payment | 2,443 | $0.67 | $1.6K | |
| Aug 3, 2023 | M. Fruchtman Steven | Executive | Payment | 4,744 | $1.01 | $4.8K | |
| Aug 3, 2023 | Patrick Guerin Mark | Executive | Payment | 1,422 | $1.02 | $1.5K | |
| Aug 2, 2023 | M. Fruchtman Steven | Executive | Option Exercise | 12,567 | $N/A | $0 | |
| Aug 2, 2023 | Patrick Guerin Mark | Executive | Option Exercise | 4,750 | $N/A | $0 | |
| Jun 12, 2023 | Patrick Guerin Mark | Executive | Payment | 1,575 | $1.14 | $1.8K | |
| Jun 12, 2023 | Patrick Guerin Mark | Executive | Option Exercise | 5,500 | $N/A | $0 | |
| Feb 7, 2023 | Patrick Guerin Mark | Executive | Option Exercise | 6,900 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 83 | $52.0M | 86.8% |
Exercise (Options)(X) | 8 | $3.1M | 5.2% |
Sale(S) | 31 | $3.0M | 5.1% |
Award(A) | 1 | $1000.0K | 1.7% |
Exercise(M) | 28 | $733.5K | 1.2% |
Payment(F) | 13 | $48.9K | 0.1% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 50 | $0 | 0.0% |
Insiders at Onconova Therapeutics, Inc. are accumulating shares at an accelerated pace. With 24 insiders making 215 transactions totaling $52.0M in purchases versus $3.0M in sales, the net buying activity of $49.0M signals strong executive confidence. Michael B. Hoffman (Executive) leads the buying activity with $19.6M in transactions across all time.